Adynovate recombinant and Etodolac Extended-Release Tablets
Determining the interaction of Adynovate recombinant and Etodolac Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: etodolac
Brand name: Lodine, Lodine XL
Synonyms: Etodolac
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate recombinant-Etomidate
- Adynovate recombinant-Etonogestrel
- Adynovate recombinant-Etonogestrel implant
- Adynovate recombinant-Etonogestrel Intradermal
- Adynovate recombinant-Etopophos
- Adynovate recombinant-Etopophos (Etoposide Injection)
- Etodolac Extended-Release Tablets-Adzenys ER
- Etodolac Extended-Release Tablets-Adzenys ER Oral Suspension
- Etodolac Extended-Release Tablets-Adzenys XR-ODT
- Etodolac Extended-Release Tablets-Aemcolo
- Etodolac Extended-Release Tablets-Aerobid
- Etodolac Extended-Release Tablets-Aerobid-M